From the Laboratory – for Clinicians

The face of Dr Jerry Radich

Chair

Professor Jerry Radich (USA)

The face of Dr Carolina Pavlovsky

Co-chair

Dr Carolina Pavlovsky (Argentina)

Chair's Overview

The face of Dr Jerry Radich

Professor Jerry Radich

Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutch, Seattle, WA, USA

CML – Main Laboratory Studies at Diagnosis

The face of Dr Carolina Pavlovsky

Dr Carolina Pavlovsky

Head Research Department, FUNDALEU, Buenos Aires, Argentina

Optimal Test Frequency for MRD

The face of Dr Carolina Pavlovsky

Dr Carolina Pavlovsky

Head Research Department, FUNDALEU, Buenos Aires, Argentina

Clinical Data to Support Each Treatment Milestone

The face of Dr Kendra Sweet

Dr Kendra Sweet

Associate Member, Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA

Essential Molecular Monitoring (focusing on low and middle income countries)

The face of Dr Jerry Radich

Professor Jerry Radich

Clinical Research Division, Kurt Enslein Endowed Chair, Fred Hutch, Seattle, WA, USA

When BCR-ABL1 Mutation Testing is Recommended

The face of Assistant Professor Simona Soverini

Assistant Professor Simona Soverini

University of Bologna, Bologna, Italy

The Role of Genomic Analysis and Panel Mutation Screening

The face of Professor Michael W. Deininger

Professor Michael W. Deininger

Medical College of Wisconsin & Versity Blood Research Institute, Milwaukee, WI, USA